Stock
US stocks closed mixed on Monday as investors assessed rising oil prices and geopolitical tensions ahead of a busy week of corporate earnings and...
Connect with us
Hi, what are you looking for?
Profit Revealed
- Stock
Dow Jones and Nasdaq 100 outlook: top stock market news for this week
S&P 500 eyes 4th straight year of double-digit gains, a rare feat in 100 years
Dow falls 1.25% as oil tops $117 and investors await Fed, big tech earnings
Nasdaq falls 2.6% as AI spending fears hit tech stocks, oil prices jump
Western Digital stock is stuck in a bear market: will it rebound after earnings?
- Business
- Politics
- Investing
Politics
After years of financial losses, Harvey Nichols has a new owner promising to turn around the struggling luxury retailer. But the takeover has not...
Investing
This preview of weekly data examines USOIL and XAUUSD, with economic data expected later this week as the primary market drivers of the near-term...
Business
IREN stock gave up an early rally on Monday, October 12, after The Information reported that the AI cloud infrastructure provider has an unannounced...
Stock
Amazon is in talks to acquire Decart, a fast-growing artificial intelligence (AI) company. According to the WSJ, Amazon is planning to buy the company...
Politics
When I was a kid, Nike was the pinnacle of cool footwear. Of course, there were other competitive athletic shoe brands like Reebok and...
Investing
A US import license is not a diesel cargo, and the cargo President Trump named is not a day of American use. The arrangement...
Business
Anthropic is reportedly preparing to meet prospective IPO investors at its San Francisco headquarters on Wednesday, October 14, bringing the Claude developer closer to...
Stock
US stocks rose on Friday as technology shares rebounded from a sell-off earlier in the week, helping Wall Street recover amid elevated Treasury yields,...
Politics
Crumbl faces two massive problems. First, the chain sells a pricey indulgence customers don’t actually need. Second, millions of Americans are taking GLP-1 drugs...
